Millen, G. C., Arnold, R., Cazier, J. -. B., Curley, H., Feltbower, R., Gamble, A., . . . Kearns, P. (2022). COVID-19 in children with haematological malignancies. Archives of Disease in Childhood, 107 (2), 186-188. doi:10.1136/archdischild-2021-322062

Palles, C., West, H. D., Chew, E., Galavotti, S., Flensburg, C., Grolleman, J. E., . . . de Voer, R. M. (2022). Germline MBD4 deficiency causes a multi-tumor predisposition syndrome. American Journal of Human Genetics, 109 (5), 953-960. doi:10.1016/j.ajhg.2022.03.018

Hurst, R., Meader, E., Gihawi, A., Rallapalli, G., Clark, J., Kay, G. L., . . . Cooper, C. S. (2022). Microbiomes of Urine and the Prostate Are Linked to Human Prostate Cancer Risk Groups. European Urology Oncology. doi:10.1016/j.euo.2022.03.006

Várnai, C., Palles, C., Arnold, R., Curley, H. M., Purshouse, K., Cheng, V. W. T., . . . Kurec, B. (2022). Mortality Among Adults With Cancer Undergoing Chemotherapy or Immunotherapy and Infected With COVID-19. JAMA Network Open, 5 (2), e220130. doi:10.1001/jamanetworkopen.2022.0130

Booth, S., Curley, H. M., Varnai, C., Arnold, R., Lee, L. Y. W., Campton, N. A., . . . Palles, C. (2021). Key findings from the UKCCMP cohort of 877 patients with haematological malignancy and COVID-19: disease control as an important factor relative to recent chemotherapy or anti-CD20 therapy. British Journal of Haematology. doi:10.1111/bjh.17937

Millen, G. C., Arnold, R., Cazier, J. -. B., Curley, H., Feltbower, R. G., Gamble, A., . . . Kearns, P. R. (2021). Severity of COVID-19 in children with cancer: Report from the United Kingdom Paediatric Coronavirus Cancer Monitoring Project. British Journal of Cancer, 124 (4), 754-759. doi:10.1038/s41416-020-01181-0

Lee, L. Y. W., Cazier, J. B., Starkey, T., Turnbull, C. D., Kerr, R., & Middleton, G. (2020). COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. The Lancet, 395 (10241), 1919-1926. doi:10.1016/s0140-6736(20)31173-9

Lee, L. Y. W., Cazier, J. -. B., Starkey, T., Briggs, S. E. W., Arnold, R., Bisht, V., . . . Hudson, Z. (2020). COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study. The Lancet Oncology. doi:10.1016/s1470-2045(20)30442-3

Anil, I., Arnold, R., Benkwitz-Beford, S., Branford, S., Campton, N., Cazier, J. -. B., . . . Varnai, C. (2020). The UK Coronavirus Cancer Monitoring Project: protecting patients with cancer in the era of COVID-19. The Lancet Oncology. doi:10.1016/s1470-2045(20)30230-8

Connell, S. P., Hanna, M., McCarthy, F., Hurst, R., Webb, M., Curley, H., . . . Clark, J. (2019). A Four-Group Urine Risk Classifier for Predicting Outcome in Prostate Cancer Patients. BJU International. doi:10.1111/bju.14811